K2 Principal Fund’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

K2 Principal Fund’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,000	Closed	-$4.34M	–	509
2021 Q1	$4.34M	Buy	+20,000	New	+$3.76M	0.34%	76

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

K2 Principal Fund's GWPH Position: Q2 2021 in Review

K2 Principal Fund sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 20,000 shares — an estimated $4.34M sold.

K2 Principal Fund first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $4.34M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

K2 Principal Fund reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
K2 Principal Fund sold 20,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.34M.
K2 Principal Fund first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
K2 Principal Fund's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.34M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on K2 Principal Fund's 13F filing for Q2 2021, filed 13 Aug 2021.